Higher Circulating Parathormone is Associated with Smaller and Weaker Bones in Obese Children
- 1 April 2014
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 95 (1) , 1-7
Abstract
Obese children have disadvantageous bone geometry, bone of low quality, and reduced strength at non-weight-bearing skeletal sites. The aim of our study was to investigate the role of parathormone (PTH) and the Wnt/β-catenin signaling pathway and its inhibitors, sclerostin and Dickkopf-1 (DKK1), as negative modulators of fat mass on bone. This was a cross-sectional observational study performed in 44 (26 males and 18 females) obese subjects, aged 11.41 ± 2.61 years. Thirty-seven normal-weight, healthy children (22 males and 15 females) of the same chronological age served as controls for the biochemical parameters and bone markers, while the data on bone geometry were evaluated according to our normative data obtained previously in a group of 325 control children. Digitalized X-rays were evaluated at the level of the second metacarpal bone for the determination of bone geometry: total cross-sectional area (TCSA), cortical area (CA), medullary area (MA), and bone strength (bending breaking resistance index [BBRI]). Serum bone markers (intact procollagen-1N-terminal propeptide [P1NP] and serum carboxy-terminal telopeptide of collagen-1 [CTX]), sclerostin, DKK1, PTH, 25-hydroxyvitamin D and were also measured. Data for TCSA, CA, MA, and BBRI are expressed as a standard deviation score in order to normalize them for age and sex. TCSA (mean ± SD, −2.92 ± 2.71), CA (−0.60 ± 0.82), MA (−0.45 ± 1.14), and BBRI (−2.65 ± 2.31) were all significantly smaller than in controls (p < 0.01). Serum PTH (36.27 ± 23.89 vs. 19.33 ± 11.37 pg/mL) and CTX (1.55 ± 0.44 vs. 1.34 ± 0.46 ng/mL) were significantly increased (p < 0.05) in the obese children compared to controls, while sclerostin was significantly decreased (24.67 ± 10.06 vs. 30.42 ± 11.01 pmol/L, p < 0.05). P1NP was also significantly increased (p < 0.01). PTH was negatively correlated with TCSA, CA, and BBRI. Bone turnover is higher in obese children than in controls, and this is associated with smaller and apparently weaker bones. Higher PTH and lower sclerostin levels may be responsible for these findings.Keywords
This publication has 46 references indexed in Scilit:
- Small metacarpal bones of low quality in obese childrenClinical Endocrinology, 2012
- Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS studyJournal of Bone and Mineral Research, 2012
- Serum Leptin, Parathyroid Hormone, 1,25-Dihydroxyvitamin D, Fibroblast Growth Factor 23, Bone Alkaline Phosphatase, and Sclerostin Relationships in ObesityThe Journal of Clinical Endocrinology & Metabolism, 2012
- Vitamin D and Hyperparathyroidism in ObesityThe Journal of Clinical Endocrinology & Metabolism, 2011
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and menJournal of Bone and Mineral Research, 2010
- Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In VivoPLOS ONE, 2009
- Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/SclerostinJournal of Biological Chemistry, 2008
- Bone mineral mass in overweight and obese children: diminished or enhanced?Acta Diabetologica, 2003
- Bone Mineral Density in Childhood ObesityJournal of Pediatric Endocrinology and Metabolism, 2000
- Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and femalesEuropean Journal of Pediatrics, 1996